WHO recommends against use of remdesivir for Covid-19

WHO issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients. This recommendation, released on 20 November, is part of a living guideline on clinical care for COVID-19, WHO said. It was developed by an international guideline development group, which includes 28 clinical care experts, 4 patient-partners and one ethicist.

The guidelines were developed in collaboration with the non-profit Magic Evidence Ecosystem Foundation (MAGIC), which provided methodologic support. The guidelines are an innovation, matching scientific standards with the speed required to respond to an ongoing pandemic.

Work on this began on 15 October when the WHO Solidarity Trial published its interim results. Data reviewed by the panel included results from this trial, as well as 3 other randomized controlled trials. In all, data from over 7000 patients across the 4 trials were considered.

The evidence suggested no important effect on mortality, need for mechanical ventilation, time to clinical improvement, and other patient-important outcomes.

The guideline development group recognized that more research is needed, especially to provide higher certainty of evidence for specific groups of patients. They supported continued enrollment in trials evaluating remdesivir.

More on this subject: Coronavirus

Similar articles

  • Israel, France to discuss Pegasus scandal

    Israel, France to discuss Pegasus scandal

    Israeli Defence Minister Benny Gantz will meet his French counterpart in Paris this week for talks that will include an "update" on the Pegasus spyware scandal, AFP reported on Tuesday, citing his office. A ministry statement said Gantz will leave Wednesday for talks with French Defence Minister Florence Parly on topics including the crisis in Lebanon, nuclear negotiations with Iran and the Pegasus malware made by Israeli firm NSO, which was allegedly used to target President Emmanuel Macron.

    30
  • World leaders can attend annual General assembly session in person

    World leaders can attend annual General assembly session in person

    The United Nations has decided to let world leaders attend their annual gathering at the UN General Assembly in September in person or deliver pre-recorded speeches if Covid-19 restrictions prevent them from traveling, news wires reported. General Assembly President Volkan Bozkir, a strong supporter of in-person meetings, said in a note from his office to the 193 UN member nations circulated on Monday that significant efforts have been made to ensure that the UN is able to host an in-person high-level week from Sept. 21-30.

    28